About India Covid-19 Detection Kit
In response to the growing COVID-19 epidemic and lack of laboratory-based molecular testing ability, several diagnostic test manufacturers have developed and started selling quick and easy-to-use devices to enable testing outside of laboratory settings. The test kits are simple to use and are based either on the detection of proteins from the COVID-19 virus in respiratory samples like sputum, throat swab, or detection, in blood or serum, of human antibodies generated in response to infection. In January 2020, India had only one laboratory testing for COVID-19 at the Indian Council of Medical Research's National Institute of Virology, Pune. Today, there are approx. 555 laboratories across the country, performing molecular tests for diagnosis of COVID-19, an unparalleled achievement in the history of the Indian health system. The RT-PCR test for COVID-19, although increasingly available around the country today, involves multiple, complex steps. First, is the sample collection using throat or nasal swabs, which are then kept in a special fluid called viral transport medium (VTM). To expedite kits produced by the industry and reduce the burden of NIV, 14 validation centers have been approved. As many as 71 kits have been evaluated to date and 28 have been approved for use. Out of these, 14 kits were indigenous ones, paving the way for self-sufficiency in testing. In order to ensure that the supplies reached every laboratory in a timely manner amid the nationwide lockdown.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
CAGR | 52.5% |
Analyst at AMA Research estimates that United States Players will contribute the maximum growth to India India Covid-19 Detection Kit market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Zydus Cadila Pharmaceutical (India), Tulips Diagnostic (India), Johnson and Johnson Medical India (India), Genei Laboratories (India) and SD Biosensor (South Korea) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Altona Diagnostics (Germany) and Mylab Discovery Solutions Pvt. Ltd. (India).
Segmentation Overview
AMA Research has segmented the market of India India Covid-19 Detection Kit market by Type (RT-PCR Assay Kits, Immunoassay Test Strips/Cassettes, ELISA (Enzyme-Linked Immunosorbent Assay) and Feluda) and Region.
On the basis of geography, the market of India Covid-19 Detection Kit has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Specimen Type, the sub-segment i.e. Nasopharyngeal Swab will boost the India Covid-19 Detection Kit market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End-Use, the sub-segment i.e. Hospitals will boost the India Covid-19 Detection Kit market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Increasing Technological Advancements in Virus Detection
Market Growth Drivers:
Rising Incidence of COVID-19 and High Risk of Infection in Geriatric Population
Challenges:
Lower Accuracy of immunoassay-Based Tests
Opportunities:
Increasing Government and Industry Players Initiatives
Market Leaders and their expansionary development strategies
In 2021, Thermo Fisher Scientific has released the CE-IVD labeled TaqPath COVID-19 HT Kit. A high-throughput COVID-19 diagnostic assay compatible with the Amplitude platform for accurate and reliable testing. This product launch has helped the company gain more market share. and In 2020, Mylab Discovery Solutions has launched the Pathocatch COVID-19 Antigen Rapid Test Kit. This kit was developed in collaboration with Gujarat-based LabCare Diagnostics. These developments have helped the company increase its market position.
From a regulatory standpoint, such kits fall under the category of ‘in-vitro diagnostic’ kits under the Drugs and Cosmetics Act, 1940 (D&C Act). FDA/CDSCO and is compliant with MDR 2017 regulation for manufacturing medical devices of Class C and D, the most stringent and regulated products by the government.
Key Target Audience
Manufacturers of COVID-19 Detective Kit, Suppliers of COVID-19 Detective Kit, Distributors and Retailers of COVID-19 Detective Kit and Governmental Bodies
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.